Results 91 to 100 of about 446,414 (163)

Histological response of peritoneal carcinomatosis after hyperthermic intraperitoneal chemoperfusion (HIPEC) in experimental investigations

BMC Cancer, 2006
Background In selected patients with peritoneal carcinomatosis from colorectal cancer prognosis can be improved by hyperthermic intraperitoneal chemotherapy (HIPEC) after cytoreductive surgery.
Dimmler A, Doerfer J, Pelz Joerg OW, Hohenberger W, Meyer T   +4 more
doaj   +1 more source

Intraperitoneal Hyperthermic Chemotherapy in Gastric Cancer: Rationale for a new Approach

, 1998
There is preliminary evidence from experience in the treatment of various abdominal malignancies that intraperitoneal chemotherapy alone or combined with hyperthermia may attain a role in the therapeutic strategy.
Federico Bozzetti, Maurizio Vaglini, Marcello Deraco   +2 more
core   +1 more source

Hyperthermic Intraperitoneal Chemotherapy in Treating Women With Pelvic Cancer: Systematic Review and Meta-analysis

, 2022
This is a systematic review of the literature to evaluate the current literature on the use of Hyperthermic Intraperitoneal Chemotherapy in treating women with pelvic cancer and to report on the added ...
Toni Horton, Hannah Palin, Sherif El-Nashar   +2 more
core   +1 more source

Cytoreductive Surgery with Hyperthermic Intraperitoneal Chemotherapy for Malignant Peritoneal Mesothelioma.

, 2012
Malignant peritoneal mesothelioma (MPM) is a rare and aggressive neoplasm that is largely resistant to traditional anti-cancer therapies. For years it has been considered a terminal condition and once diagnosed, patients generally survived less than a ...
Blackham, Aaron U, MD, Levine, Edward A
core   +1 more source

Long-term survival of high-grade primary peritoneal papillary serous adenocarcinoma: a case report and literature review

World Journal of Surgical Oncology, 2017
Background Primary peritoneal papillary serous carcinoma (PPPSC) is an uncommon disease which has a high malignancy and a poor prognosis. Case presentation We report here a long-term survival case of PPPSC with postoperative lung metastasis.
Jingping Yuan, Liang He, Bing Han, Yan Li   +3 more
doaj   +1 more source

Selection of chemotherapy for hyperthermic intraperitoneal use in gastric cancer [PDF]

, 2015
Purpose: Several studies have shown the potential benefit of cytoreductive surgery combined with hyperthermic intraperitoneal chemotherapy (HIPEC) in gastric cancer patients.
Knibbe, C. A., Braam, H. J., van Sandick, J. W., Pharmacoepidemiology and Clinical Pharmacology, Boerma, D., van Ramshorst, B., Sub Clinical Pharmacology, Schellens, J. H., Boot, H.   +8 more
core   +1 more source

Hyperthermic intraperitoneal chemotherapy at the primary gastrointestinal cancer operation

, 2017
Up to 20% of the patients who undergo radical surgery for colorectal cancer experience recurrence. Hyperthermic intraperitoneal chemotherapy (HIPEC) and cytoreductive surgery have shown to be effective treatment of peritoneal carcinomatosis.
Pommergaard, Hans-Christian, Degett, Thea Helene, Gögenur, Ismail   +2 more
core   +1 more source

Assessment of Hyperthermic Intraperitoneal Chemotherapy to Eradicate Intraperitoneal Free Cancer Cells

Translational Oncology, 2016
OBJECTIVE: To assess the effect of hyperthermic intraperitoneal chemotherapy (HIPEC) to eradicate intraperitoneal free cancer cells and to explore the feasibility of cytological cure for peritoneal carcinomatosis (PC).
Zhonghe Ji, Jianhua Sun, Haitao Wu, Qian Zhang, Kaiwen Peng, Yan Li   +5 more
doaj   +1 more source

Hyperthermic intraperitoneal chemotherapy is an independent risk factor for development of acute kidney injury

, 2020
Purpose: Cytoreductive surgery combined with hyperthermic intraperitoneal chemotherapy (HIPEC) or hyperthermic intrapleural chemotherapy (HIC) has been established as the new treatment modality for selected patients with peritoneal and pleural ...
Dagel, Tuncay, Vatansever, Dogan, Dilege, Sukru, Yalti, Tunc, AFŞAR, Barış, Misirlioglu, Selim, Bugra, Dursun, Erus, Suat, Kanbay, Mehmet, Tanju, Serhan, Selcukbiriciks, Fatih, Mandel, Nil Molinas, Bank, Emre, Taskiran, Cagatay   +13 more
core  

Efficacy and safety of intraperitoneal chemotherapy for pancreatic cancer

BMC Surgery
Pancreatic cancer is a highly aggressive cancer with unfavorable prognosis despite the therapeutic interventions. Intraperitoneal chemotherapy has recently shown potential outcomes in the presence of peritoneal metastases.
Dorsa Safari, Mohammad Fakhrolmobasheri, Saeed Soleymanjahi   +2 more
doaj   +1 more source